Cargando…

CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade

Cerebral spinal fluid (CSF) and structural imaging markers are suggested as biomarkers amended to existing diagnostic criteria of mild cognitive impairment (MCI) and Alzheimer's disease (AD). But there is no clear instruction on which markers should be used at which stage of dementia. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xianfeng, Tan, Ming Zhen, Qiu, Anqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526616/ https://www.ncbi.nlm.nih.gov/pubmed/23284610 http://dx.doi.org/10.1371/journal.pone.0047406

Ejemplares similares

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology
por: Miners, J. S., et al.
Publicado: (2019)

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
por: Jiang, Richeng, et al.
Publicado: (2022)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
por: Dong, Ruocheng, et al.
Publicado: (2023)

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies
por: Mistur, Rachel, et al.
Publicado: (2009)

Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
por: Salvadó, Gemma, et al.
Publicado: (2022)

Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes
por: Cicognola, Claudia, et al.
Publicado: (2023)

Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain
por: Rao, J S, et al.
Publicado: (2011)

Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?
por: Boesenberg-Grosse, Constanze, et al.
Publicado: (2006)

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2022)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4
por: Andreasson, U, et al.
Publicado: (2014)

Biomarker A+T−: is this Alzheimer’s disease or not? A combined CSF and pathology study
por: Vromen, Eleonora M, et al.
Publicado: (2022)

Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
por: Barranco, Neus, et al.
Publicado: (2021)

One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond
por: Dayon, Loïc, et al.
Publicado: (2017)

Association between serum urate and CSF markers of Alzheimer's disease pathology in a population‐based sample of 70‐year‐olds
por: Fatima, Tahzeeb, et al.
Publicado: (2021)

Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
por: Kant, Shawn, et al.
Publicado: (2018)

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
por: Miners, James, et al.
Publicado: (2023)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Age dependent contribution of entry via the CSF to the overall brain entry of small and large hydrophilic markers
por: Qiu, Fiona, et al.
Publicado: (2022)

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
por: Contador, José, et al.
Publicado: (2021)

Imaging hydrogen peroxide in Alzheimer’s disease via cascade signal amplification
por: Yang, Jian, et al.
Publicado: (2016)

Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease
por: Han, Qiu, et al.
Publicado: (2018)

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
por: Tang, Lian, et al.
Publicado: (2022)

Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease
por: Morenas-Rodríguez, Estrella, et al.
Publicado: (2019)

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
por: Brier, Matthew R., et al.
Publicado: (2016)

Identifying genetic markers enriched by brain imaging endophenotypes in Alzheimer’s disease
por: Kim, Mansu, et al.
Publicado: (2022)

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2022)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases
por: Halbgebauer, Steffen, et al.
Publicado: (2022)

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017)

CSF Biomarkers for Alzheimer's Disease Diagnosis
por: Anoop, A., et al.
Publicado: (2010)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
por: Dong, Ruocheng, et al.
Publicado: (2021)

Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?
por: Tan, Zaldy S, et al.
Publicado: (2010)

Imaging Brain Metabolism and Pathology in Alzheimer’s Disease with Positron Emission Tomography
por: Shokouhi, S, et al.
Publicado: (2014)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

Pathological Human Tau Induces Alterations in the Brain Insulin Signaling Cascade
por: El Idrissi, Abdeslem, et al.
Publicado: (2022)

Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology
por: Olmos-Alonso, Adrian, et al.
Publicado: (2016)

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
por: Remnestål, Julia, et al.
Publicado: (2016)

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
por: Bergström, Sofia, et al.
Publicado: (2021)

Cascade autohydrolysis of Alzheimer's Aβ peptides
por: Wolfram, Martin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qejbql91cap58b13pbeco2bpm4